Long-term Natural History of Lower Urinary Tract Symptoms Following Radical Retropubic Prostatectomy: A Prospective 15-Year Longitudinal Study



      To provide insights into the long-term impact of radical retro-pubic prostatectomy (ORRP) on lower urinary tract symptoms (LUTS) which are age and prostate dependent and adversely impact quality of life.


      1995 men undergoing ORRP enrolled in a prospective longitudinal outcomes study. The American Urological Association Symptom Index was self-administered before ORRP and at predetermined time-points after surgery. A multivariate generalized linear model was used to evaluate the association of time since ORRP with American Urological Association symptom score (AUASS). McNemar's test and paired sample t-tests were used to assess whether the proportion of men with clinically significant LUTS (CSLUTS) defined by an AUASS >7 or mean AUASS differed significantly between the time-dependent assessments, respectively.


      The 15-year mean adjusted AUASS was similar to baseline (7.00 vs 6.85, P = .66). Throughout the 15 years of follow-up, the proportion of men with CSLUTS was lower than baseline with the exception of the 3 month and 15 year assessments. Among men with baseline clinically insignificant LUTS (CILUTS), the mean adjusted AUASS at 15 years was significantly greater than baseline (6.09 vs 3.19, P < .001). Among men with baseline CSLUTS, ORRP led to a significant decrease in mean adjusted AUASS between baseline and 15 years (13.26 vs 8.67, P < .001).


      ORRP favorably affects the long-term natural history of LUTS. The long-term economic and quality of life benefits of ORRP on LUTS should inform the risks and benefits of RP for treatment of localized prostate cancer.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Urology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Carbone Jr., DJ
        • Hodges S
        Medical therapy for benign prostatic hyperplasia: sexual dysfunction and impact on quality of life.
        Int J Impot Res. 2003; 15: 299-306
        • Platz EA
        • Joshu CE
        • Mondul AM
        • et al.
        Incidence and progression of lower urinary tract symptoms in a large prospective cohort of United States men.
        J Urol. 2012; 188: 496-501
        • McVary KT
        • Roehrborn CG
        • Avins AL
        • et al.
        Update on AUA guideline on the management of benign prostatic hyperplasia.
        J Urol. 2011; 185: 1793-1803
        • Lepor H
        • Rigaud G
        The efficacy of transurethral resection of the prostate in men with moderate symptoms of prostatism.
        J Urol. 1990; 143: 533-537
        • Schwartz EJ
        • Lepor H
        Radical retropubic prostatectomy reduces symptom scores and improves quality of life in men with moderate and severe lower urinary tract symptoms.
        J Urol. 1999; 161: 1185-1188
        • Prabhu V
        • Taksler GB
        • Sivarajan G
        • et al.
        Radical prostatectomy improves and prevents age dependent progression of lower urinary tract symptoms.
        J Urol. 2014; 191: 412-417
        • Eggener SE
        • Scardino PT
        • Walsh PC
        • et al.
        Predicting 15-year prostate cancer specific mortality after radical prostatectomy.
        J Urol. 2011; 185: 869-875
        • McConnell JD
        • Roehrborn CG
        • Bautista OM
        • et al.
        The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia.
        N Engl J Med. 2003; 349: 2387-2398
        • Barry MJ
        • Fowler Jr., FJ
        • O'Leary MP
        • et al.
        The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association.
        J Urol. 1992; 148 (discussion 64): 1549-1557
        • Sarma AV
        • Wei JT
        Clinical practice. Benign prostatic hyperplasia and lower urinary tract symptoms.
        N Engl J Med. 2012; 367: 248-257
        • Madersbacher S
        • Alivizatos G
        • Nordling J
        • et al.
        EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines).
        Eur Urol. 2004; 46: 547-554
        • Malmsten UG
        • Molander U
        • Peeker R
        • et al.
        Urinary incontinence, overactive bladder, and other lower urinary tract symptoms: a longitudinal population-based survey in men aged 45-103 years.
        Eur Urol. 2010; 58: 149-156
        • Lewis RW
        • Fugl-Meyer KS
        • Corona G
        • et al.
        Definitions/epidemiology/risk factors for sexual dysfunction.
        J Sex Med. 2010; 7: 1598-1607
        • Sarma AV
        • Jacobsen SJ
        • Girman CJ
        • et al.
        Concomitant longitudinal changes in frequency of and bother from lower urinary tract symptoms in community dwelling men.
        J Urol. 2002; 168: 1446-1452
        • Resnick MJ
        • Koyama T
        • Fan KH
        • et al.
        Long-term functional outcomes after treatment for localized prostate cancer.
        N Engl J Med. 2013; 368: 436-445
        • Chute CG
        • Panser LA
        • Girman CJ
        • et al.
        The prevalence of prostatism: a population-based survey of urinary symptoms.
        J Urol. 1993; 150: 85-89
        • Fukuta F
        • Masumori N
        • Mori M
        • et al.
        Natural history of lower urinary tract symptoms in Japanese men from a 15-year longitudinal community-based study.
        BJU Int. 2012; 110: 1023-1029
        • Barry MJ
        • Williford WO
        • Chang Y
        • et al.
        Benign prostatic hyperplasia specific health status measures in clinical research: how much change in the American Urological Association symptom index and the benign prostatic hyperplasia impact index is perceptible to patients?.
        J Urol. 1995; 154: 1770-1774
        • Lepor H
        Pathophysiology of lower urinary tract symptoms in the aging male population.
        Rev Urol. 2005; 7: S3-S11
        • Lepor H
        • Kaci L
        Contemporary evaluation of operative parameters and complications related to open radical retropubic prostatectomy.
        Urology. 2003; 62: 702-706
        • Sultan R
        • Slova D
        • Thiel B
        • et al.
        Time to return to work and physical activity following open radical retropubic prostatectomy.
        J Urol. 2006; 176: 1420-1423
        • Lepor H
        • Kaci L
        • Xue X
        Continence following radical retropubic prostatectomy using self-reporting instruments.
        J Urol. 2004; 171: 1212-1215
        • Kundu SD
        • Roehl KA
        • Eggener SE
        • et al.
        Potency, continence and complications in 3,477 consecutive radical retropubic prostatectomies.
        J Urol. 2004; 172: 2227-2231
        • Bacon CG
        • Mittleman MA
        • Kawachi I
        • et al.
        Sexual function in men older than 50 years of age: results from the health professionals follow-up study.
        Ann Intern Med. 2003; 139: 161-168